Tocopherols and Tocotrienols Prevent Lipoxygenase‐driven Phospholipid Oxidation in Ferroptosis

Gaowei Mao,Feng Qu,José Pedro Friedmann Angeli,Claudette St. Croix,Haider H. Dar,Vladimir A. Tyurin,Vladimir B. Ritov,Alexandr A. Kapralov,Andrew A. Amoscato,Tamil S. Anthonymuthu,Dariush Mohammadyani,Qin Yang,Brent R. Stockwell,Yulia Y. Tyurina,Marcus Conrad,Hülya Bayır,Valerian E. Kagan

DOI: https://doi.org/10.1096/fasebj.31.1_supplement.946.3

2017-01-01

Abstract:Ferroptosis, a recently discovered regulated necrotic pathway, has been claimed to include a required stage of lipid peroxidation. However, neither the nature of oxidized lipid species nor their subcellular location and enzymatic generators have been identified. We established that inactivation or depletion of glutathione peroxidase 4 (Gpx4) induced ferroptosis in mouse embryonic fibroblasts (MEFs). Using mitochondria and endoplasmic reticulum (ER) targeted fluorogen‐activating proteins (Mito‐FAP and ER‐FAP), we demonstrated that generation of oxidized lipids predominantly occurred in the ER compartment. We further showed that oxidized arachidonoyl‐ and adrenoyl‐phosphatidylethanol‐amines (but not oxygenated free fatty acids) were the major players in the execution of ferroptosis. Formation of the oxidized phospholipids was predominantly catalyzed by 15‐lipoxygenases (LOX). Vitamin E homologues (tocopherols and tocotrienols) bind with the catalytic site of LOX and suppress ferroptosis, revealing a potential non‐canonical mechanism of action of vitamin E in protection against ferroptosis likely realized independently of radical scavenging. Taken together, these findings decipher molecular mechanisms of ferroptosis and provide new therapeutic targets. Support or Funding Information US National Institutes of Health (NS076511 to V.E.K., NS061817 to H.B., and ES020693 to Y.Y.T.), the Human Frontier Science Program (HFSP‐RGP0013/2014), and the Deutsche Forschungsgemeinschaft (CO 291/2‐3 and CO 291/5‐1) to M.C.